Infectious disease comorbidities adversely affecting substance users with HIV: hepatitis C and tuberculosis.
about
Hepatitis C treatment access and uptake for people who inject drugs: a review mapping the role of social factorsUtilizing buprenorphine-naloxone to treat illicit and prescription-opioid dependenceEnhanced tuberculosis case detection among substitution treatment patients: a randomized controlled trialCoexisting social conditions and health problems among clients seeking treatment for illicit drug use in Finland: the HUUTI study.Prevention and treatment of HIV/AIDS among drug-using populations: a global perspectiveSeverity of psychiatric and physical problems is associated with lower quality of life in methadone patients in Indonesia.Improving public health through access to and utilization of medication assisted treatmentChallenges in managing HIV in people who use drugsRifampin, but not rifabutin, may produce opiate withdrawal in buprenorphine-maintained patientsTuberculosis screening in a novel substance abuse treatment center in Malaysia: implications for a comprehensive approach for integrated care.Prevalence of hepatitis C virus and human immunodeficiency virus in a group of patients newly diagnosed with active tuberculosis in Porto Alegre, Southern Brazil.A syndemic approach to assess the effect of substance use and social disparities on the evolution of HIV/HCV infections in British Columbia.Characterization of hepatitis C infection in tuberculosis patients in an urban city in the USA.Guidelines for improving entry into and retention in care and antiretroviral adherence for persons with HIV: evidence-based recommendations from an International Association of Physicians in AIDS Care panel
P2860
Q26853671-5A98EF49-BCF1-4885-8554-4E14A1FD817AQ26865674-7AD75ED2-DBA2-4EA6-8BF4-0E852AF8569DQ33933639-8AABF008-4AA4-47CA-A85B-154A9FEDCB77Q34687009-E50C081A-25D5-4C4C-8ECF-D72BBCC49B54Q34780130-D6DEC530-9C09-49B2-B4D5-E8870396090FQ34953130-500E26A9-7C0B-4999-AEB3-4A7F0B9BB028Q35534893-0BADE879-9862-4A9D-A1A3-39AB286A0266Q35538674-54D6010C-FA8C-4D16-9676-A903C2129799Q35738885-ABD97FB7-B4D4-430F-9BB7-1C755E477132Q37536255-48B319A9-D444-45D1-98A5-D6C03ABAFF87Q37705730-B820432F-BA25-4DAF-A7DD-1CDC38EFDD80Q40075326-22734F39-97BD-4EA2-9340-37D94D3E0392Q40139704-8E8F79E6-2DBD-4B7B-A77D-ED1D49B6C750Q56973152-5252608A-A7B5-4803-AD9E-038F82C9869A
P2860
Infectious disease comorbidities adversely affecting substance users with HIV: hepatitis C and tuberculosis.
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Infectious disease comorbiditi ...... hepatitis C and tuberculosis.
@ast
Infectious disease comorbiditi ...... hepatitis C and tuberculosis.
@en
type
label
Infectious disease comorbiditi ...... hepatitis C and tuberculosis.
@ast
Infectious disease comorbiditi ...... hepatitis C and tuberculosis.
@en
prefLabel
Infectious disease comorbiditi ...... hepatitis C and tuberculosis.
@ast
Infectious disease comorbiditi ...... hepatitis C and tuberculosis.
@en
P2860
P1476
Infectious disease comorbiditi ...... hepatitis C and tuberculosis.
@en
P2093
Gerald Friedland
P2860
P304
P356
10.1097/QAI.0B013E3181F9C0B6
P407
P478
55 Suppl 1
P577
2010-12-01T00:00:00Z